 | • レポートコード：MRC2Q12-17358 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、76ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、冠動脈疾患用医薬品コーティングバルーンの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に冠動脈疾患用医薬品コーティングバルーンのグローバル市場のxxx％を占める「パクリタキセルコーティング」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 冠動脈疾患用医薬品コーティングバルーンの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの冠動脈疾患用医薬品コーティングバルーン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 冠動脈疾患用医薬品コーティングバルーンのグローバル主要プレイヤーには、B. Braun、Yinyi、Eurocor、Biotronicなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 冠動脈疾患用医薬品コーティングバルーン市場は、種類と用途によって区分されます。世界の冠動脈疾患用医薬品コーティングバルーン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 パクリタキセルコーティング、その他コーティング 【用途別セグメント】 病院、ASC、カテーテル検査室 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 冠動脈疾患用医薬品コーティングバルーン製品概要 - 種類別市場（パクリタキセルコーティング、その他コーティング） - 用途別市場（病院、ASC、カテーテル検査室） - 調査の目的 ・エグゼクティブサマリー - 世界の冠動脈疾患用医薬品コーティングバルーン販売量予測2017-2028 - 世界の冠動脈疾患用医薬品コーティングバルーン売上予測2017-2028 - 冠動脈疾患用医薬品コーティングバルーンの地域別販売量 - 冠動脈疾患用医薬品コーティングバルーンの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別冠動脈疾患用医薬品コーティングバルーン販売量 - 主要メーカー別冠動脈疾患用医薬品コーティングバルーン売上 - 主要メーカー別冠動脈疾患用医薬品コーティングバルーン価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（パクリタキセルコーティング、その他コーティング） - 冠動脈疾患用医薬品コーティングバルーンの種類別販売量 - 冠動脈疾患用医薬品コーティングバルーンの種類別売上 - 冠動脈疾患用医薬品コーティングバルーンの種類別価格 ・用途別市場規模（病院、ASC、カテーテル検査室） - 冠動脈疾患用医薬品コーティングバルーンの用途別販売量 - 冠動脈疾患用医薬品コーティングバルーンの用途別売上 - 冠動脈疾患用医薬品コーティングバルーンの用途別価格 ・北米市場 - 北米の冠動脈疾患用医薬品コーティングバルーン市場規模（種類別、用途別） - 主要国別の冠動脈疾患用医薬品コーティングバルーン市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの冠動脈疾患用医薬品コーティングバルーン市場規模（種類別、用途別） - 主要国別の冠動脈疾患用医薬品コーティングバルーン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の冠動脈疾患用医薬品コーティングバルーン市場規模（種類別、用途別） - 主要国別の冠動脈疾患用医薬品コーティングバルーン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の冠動脈疾患用医薬品コーティングバルーン市場規模（種類別、用途別） - 主要国別の冠動脈疾患用医薬品コーティングバルーン市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの冠動脈疾患用医薬品コーティングバルーン市場規模（種類別、用途別） - 主要国別の冠動脈疾患用医薬品コーティングバルーン市場規模（トルコ、サウジアラビア） ・企業情報 B. Braun、Yinyi、Eurocor、Biotronic ・産業チェーン及び販売チャネル分析 - 冠動脈疾患用医薬品コーティングバルーンの産業チェーン分析 - 冠動脈疾患用医薬品コーティングバルーンの原材料 - 冠動脈疾患用医薬品コーティングバルーンの生産プロセス - 冠動脈疾患用医薬品コーティングバルーンの販売及びマーケティング - 冠動脈疾患用医薬品コーティングバルーンの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 冠動脈疾患用医薬品コーティングバルーンの産業動向 - 冠動脈疾患用医薬品コーティングバルーンのマーケットドライバー - 冠動脈疾患用医薬品コーティングバルーンの課題 - 冠動脈疾患用医薬品コーティングバルーンの阻害要因 ・主な調査結果 |
The DEB may become a viable alternative treatment option for the inhibition of coronary restenosis and subsequent revascularisation, as it allows local release of a high-concentration antirestenotic drug, paclitaxel, into the coronary vessel without using a metal scaffold or durable polymers.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Drug-Coated Balloon for Coronary Artery Disease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Drug-Coated Balloon for Coronary Artery Disease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Drug-Coated Balloon for Coronary Artery Disease is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Drug-Coated Balloon for Coronary Artery Disease include B. Braun, Yinyi, Eurocor and Biotronic, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Drug-Coated Balloon for Coronary Artery Disease manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Drug-Coated Balloon for Coronary Artery Disease market. Further, it explains the major drivers and regional dynamics of the global Drug-Coated Balloon for Coronary Artery Disease market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
B. Braun
Yinyi
Eurocor
Biotronic
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Drug-Coated Balloon for Coronary Artery Disease Segment by Type
Paclitaxel Coated
Other Coated
Drug-Coated Balloon for Coronary Artery Disease Segment by Application
Hospitals
ASCs
Catheterization Laboratory
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug-Coated Balloon for Coronary Artery Disease market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Drug-Coated Balloon for Coronary Artery Disease, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Drug-Coated Balloon for Coronary Artery Disease, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Drug-Coated Balloon for Coronary Artery Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Drug-Coated Balloon for Coronary Artery Disease sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Drug-Coated Balloon for Coronary Artery Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Drug-Coated Balloon for Coronary Artery Disease sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including B. Braun, Yinyi, Eurocor and Biotronic, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Drug-Coated Balloon for Coronary Artery Disease in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Drug-Coated Balloon for Coronary Artery Disease manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug-Coated Balloon for Coronary Artery Disease sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Drug-Coated Balloon for Coronary Artery Disease Product Introduction
1.2 Market by Type
1.2.1 Global Drug-Coated Balloon for Coronary Artery Disease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Paclitaxel Coated
1.2.3 Other Coated
1.3 Market by Application
1.3.1 Global Drug-Coated Balloon for Coronary Artery Disease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 ASCs
1.3.4 Catheterization Laboratory
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales Estimates and Forecasts 2017-2028
2.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue Estimates and Forecasts 2017-2028
2.3 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Region
2.4.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2017-2022)
2.4.2 Global Sales Drug-Coated Balloon for Coronary Artery Disease by Region (2023-2028)
2.5 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region
2.5.1 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2017-2022)
2.5.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Manufacturers
3.1.1 Global Top Drug-Coated Balloon for Coronary Artery Disease Manufacturers by Sales (2017-2022)
3.1.2 Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Drug-Coated Balloon for Coronary Artery Disease in 2021
3.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Manufacturers
3.2.1 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Manufacturers (2017-2022)
3.2.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Drug-Coated Balloon for Coronary Artery Disease Revenue in 2021
3.3 Global Drug-Coated Balloon for Coronary Artery Disease Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Drug-Coated Balloon for Coronary Artery Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Drug-Coated Balloon for Coronary Artery Disease Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Type
4.1.1 Global Drug-Coated Balloon for Coronary Artery Disease Historical Sales by Type (2017-2022)
4.1.2 Global Drug-Coated Balloon for Coronary Artery Disease Forecasted Sales by Type (2023-2028)
4.1.3 Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2017-2028)
4.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Type
4.2.1 Global Drug-Coated Balloon for Coronary Artery Disease Historical Revenue by Type (2017-2022)
4.2.2 Global Drug-Coated Balloon for Coronary Artery Disease Forecasted Revenue by Type (2023-2028)
4.2.3 Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2017-2028)
4.3 Global Drug-Coated Balloon for Coronary Artery Disease Price by Type
4.3.1 Global Drug-Coated Balloon for Coronary Artery Disease Price by Type (2017-2022)
4.3.2 Global Drug-Coated Balloon for Coronary Artery Disease Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Drug-Coated Balloon for Coronary Artery Disease Sales by Application
5.1.1 Global Drug-Coated Balloon for Coronary Artery Disease Historical Sales by Application (2017-2022)
5.1.2 Global Drug-Coated Balloon for Coronary Artery Disease Forecasted Sales by Application (2023-2028)
5.1.3 Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2017-2028)
5.2 Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Application
5.2.1 Global Drug-Coated Balloon for Coronary Artery Disease Historical Revenue by Application (2017-2022)
5.2.2 Global Drug-Coated Balloon for Coronary Artery Disease Forecasted Revenue by Application (2023-2028)
5.2.3 Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2017-2028)
5.3 Global Drug-Coated Balloon for Coronary Artery Disease Price by Application
5.3.1 Global Drug-Coated Balloon for Coronary Artery Disease Price by Application (2017-2022)
5.3.2 Global Drug-Coated Balloon for Coronary Artery Disease Price Forecast by Application (2023-2028)
6 North America
6.1 North America Drug-Coated Balloon for Coronary Artery Disease Market Size by Type
6.1.1 North America Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2028)
6.1.2 North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2028)
6.2 North America Drug-Coated Balloon for Coronary Artery Disease Market Size by Application
6.2.1 North America Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2028)
6.2.2 North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2028)
6.3 North America Drug-Coated Balloon for Coronary Artery Disease Market Size by Country
6.3.1 North America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2017-2028)
6.3.2 North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Drug-Coated Balloon for Coronary Artery Disease Market Size by Type
7.1.1 Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2028)
7.1.2 Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2028)
7.2 Europe Drug-Coated Balloon for Coronary Artery Disease Market Size by Application
7.2.1 Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2028)
7.2.2 Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2028)
7.3 Europe Drug-Coated Balloon for Coronary Artery Disease Market Size by Country
7.3.1 Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2017-2028)
7.3.2 Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Market Size by Type
8.1.1 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2028)
8.1.2 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2028)
8.2 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Market Size by Application
8.2.1 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2028)
8.2.2 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2028)
8.3 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Market Size by Region
8.3.1 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2017-2028)
8.3.2 Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Drug-Coated Balloon for Coronary Artery Disease Market Size by Type
9.1.1 Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2028)
9.1.2 Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2028)
9.2 Latin America Drug-Coated Balloon for Coronary Artery Disease Market Size by Application
9.2.1 Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2028)
9.2.2 Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2028)
9.3 Latin America Drug-Coated Balloon for Coronary Artery Disease Market Size by Country
9.3.1 Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2017-2028)
9.3.2 Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Market Size by Type
10.1.1 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2028)
10.1.2 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2028)
10.2 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Market Size by Application
10.2.1 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2028)
10.2.2 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2028)
10.3 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Market Size by Country
10.3.1 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2017-2028)
10.3.2 Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 B. Braun
11.1.1 B. Braun Corporation Information
11.1.2 B. Braun Overview
11.1.3 B. Braun Drug-Coated Balloon for Coronary Artery Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 B. Braun Drug-Coated Balloon for Coronary Artery Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 B. Braun Recent Developments
11.2 Yinyi
11.2.1 Yinyi Corporation Information
11.2.2 Yinyi Overview
11.2.3 Yinyi Drug-Coated Balloon for Coronary Artery Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Yinyi Drug-Coated Balloon for Coronary Artery Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Yinyi Recent Developments
11.3 Eurocor
11.3.1 Eurocor Corporation Information
11.3.2 Eurocor Overview
11.3.3 Eurocor Drug-Coated Balloon for Coronary Artery Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eurocor Drug-Coated Balloon for Coronary Artery Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eurocor Recent Developments
11.4 Biotronic
11.4.1 Biotronic Corporation Information
11.4.2 Biotronic Overview
11.4.3 Biotronic Drug-Coated Balloon for Coronary Artery Disease Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Biotronic Drug-Coated Balloon for Coronary Artery Disease Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biotronic Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Drug-Coated Balloon for Coronary Artery Disease Industry Chain Analysis
12.2 Drug-Coated Balloon for Coronary Artery Disease Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Drug-Coated Balloon for Coronary Artery Disease Production Mode & Process
12.4 Drug-Coated Balloon for Coronary Artery Disease Sales and Marketing
12.4.1 Drug-Coated Balloon for Coronary Artery Disease Sales Channels
12.4.2 Drug-Coated Balloon for Coronary Artery Disease Distributors
12.5 Drug-Coated Balloon for Coronary Artery Disease Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Drug-Coated Balloon for Coronary Artery Disease Industry Trends
13.2 Drug-Coated Balloon for Coronary Artery Disease Market Drivers
13.3 Drug-Coated Balloon for Coronary Artery Disease Market Challenges
13.4 Drug-Coated Balloon for Coronary Artery Disease Market Restraints
14 Key Findings in The Global Drug-Coated Balloon for Coronary Artery Disease Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Drug-Coated Balloon for Coronary Artery Disease Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Paclitaxel Coated
Table 3. Major Manufacturers of Other Coated
Table 4. Global Drug-Coated Balloon for Coronary Artery Disease Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2017-2022) & (Units)
Table 7. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Region (2017-2022)
Table 8. Global Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2023-2028) & (Units)
Table 9. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Region (2023-2028)
Table 10. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Region (2017-2022)
Table 12. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Region (2023-2028)
Table 14. Global Drug-Coated Balloon for Coronary Artery Disease Sales by Manufacturers (2017-2022) & (Units)
Table 15. Global Drug-Coated Balloon for Coronary Artery Disease Sales Share by Manufacturers (2017-2022)
Table 16. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Manufacturers (2017-2022)
Table 18. Drug-Coated Balloon for Coronary Artery Disease Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Drug-Coated Balloon for Coronary Artery Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Drug-Coated Balloon for Coronary Artery Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Coated Balloon for Coronary Artery Disease as of 2021)
Table 21. Drug-Coated Balloon for Coronary Artery Disease Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Drug-Coated Balloon for Coronary Artery Disease Product Offered
Table 23. Date of Manufacturers Enter into Drug-Coated Balloon for Coronary Artery Disease Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2022) & (Units)
Table 26. Global Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2023-2028) & (Units)
Table 27. Global Drug-Coated Balloon for Coronary Artery Disease Sales Share by Type (2017-2022)
Table 28. Global Drug-Coated Balloon for Coronary Artery Disease Sales Share by Type (2023-2028)
Table 29. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Type (2017-2022)
Table 32. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Type (2023-2028)
Table 33. Drug-Coated Balloon for Coronary Artery Disease Price by Type (2017-2022) & (US$/Unit)
Table 34. Global Drug-Coated Balloon for Coronary Artery Disease Price Forecast by Type (2023-2028) & (US$/Unit)
Table 35. Global Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2022) & (Units)
Table 36. Global Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2023-2028) & (Units)
Table 37. Global Drug-Coated Balloon for Coronary Artery Disease Sales Share by Application (2017-2022)
Table 38. Global Drug-Coated Balloon for Coronary Artery Disease Sales Share by Application (2023-2028)
Table 39. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Application (2017-2022)
Table 42. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Application (2023-2028)
Table 43. Drug-Coated Balloon for Coronary Artery Disease Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Drug-Coated Balloon for Coronary Artery Disease Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2022) & (Units)
Table 46. North America Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2023-2028) & (Units)
Table 47. North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2022) & (Units)
Table 50. North America Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2023-2028) & (Units)
Table 51. North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2017-2022) & (Units)
Table 54. North America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2023-2028) & (Units)
Table 55. North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2022) & (Units)
Table 58. Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2023-2028) & (Units)
Table 59. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2022) & (Units)
Table 62. Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2023-2028) & (Units)
Table 63. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2017-2022) & (Units)
Table 66. Europe Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2023-2028) & (Units)
Table 67. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2022) & (Units)
Table 70. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2023-2028) & (Units)
Table 71. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2022) & (Units)
Table 74. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2023-2028) & (Units)
Table 75. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2017-2022) & (Units)
Table 78. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales by Region (2023-2028) & (Units)
Table 79. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2022) & (Units)
Table 82. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2023-2028) & (Units)
Table 83. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2022) & (Units)
Table 86. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2023-2028) & (Units)
Table 87. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2017-2022) & (Units)
Table 90. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2023-2028) & (Units)
Table 91. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2017-2022) & (Units)
Table 94. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Type (2023-2028) & (Units)
Table 95. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2017-2022) & (Units)
Table 98. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Application (2023-2028) & (Units)
Table 99. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2017-2022) & (Units)
Table 102. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales by Country (2023-2028) & (Units)
Table 103. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue by Country (2023-2028) & (US$ Million)
Table 105. B. Braun Corporation Information
Table 106. B. Braun Description and Major Businesses
Table 107. B. Braun Drug-Coated Balloon for Coronary Artery Disease Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. B. Braun Drug-Coated Balloon for Coronary Artery Disease Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. B. Braun Recent Developments
Table 110. Yinyi Corporation Information
Table 111. Yinyi Description and Major Businesses
Table 112. Yinyi Drug-Coated Balloon for Coronary Artery Disease Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Yinyi Drug-Coated Balloon for Coronary Artery Disease Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Yinyi Recent Developments
Table 115. Eurocor Corporation Information
Table 116. Eurocor Description and Major Businesses
Table 117. Eurocor Drug-Coated Balloon for Coronary Artery Disease Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Eurocor Drug-Coated Balloon for Coronary Artery Disease Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Eurocor Recent Developments
Table 120. Biotronic Corporation Information
Table 121. Biotronic Description and Major Businesses
Table 122. Biotronic Drug-Coated Balloon for Coronary Artery Disease Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. Biotronic Drug-Coated Balloon for Coronary Artery Disease Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Biotronic Recent Developments
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Drug-Coated Balloon for Coronary Artery Disease Distributors List
Table 128. Drug-Coated Balloon for Coronary Artery Disease Customers List
Table 129. Drug-Coated Balloon for Coronary Artery Disease Market Trends
Table 130. Drug-Coated Balloon for Coronary Artery Disease Market Drivers
Table 131. Drug-Coated Balloon for Coronary Artery Disease Market Challenges
Table 132. Drug-Coated Balloon for Coronary Artery Disease Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug-Coated Balloon for Coronary Artery Disease Product Picture
Figure 2. Global Drug-Coated Balloon for Coronary Artery Disease Market Share by Type in 2021 & 2028
Figure 3. Paclitaxel Coated Product Picture
Figure 4. Other Coated Product Picture
Figure 5. Global Drug-Coated Balloon for Coronary Artery Disease Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. ASCs
Figure 8. Catheterization Laboratory
Figure 9. Drug-Coated Balloon for Coronary Artery Disease Report Years Considered
Figure 10. Global Drug-Coated Balloon for Coronary Artery Disease Sales 2017-2028 (Units)
Figure 11. Global Drug-Coated Balloon for Coronary Artery Disease Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Drug-Coated Balloon for Coronary Artery Disease Revenue 2017-2028 (US$ Million)
Figure 13. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Region (2017-2022)
Figure 15. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Region (2023-2028)
Figure 16. North America Drug-Coated Balloon for Coronary Artery Disease Sales YoY (2017-2028) & (Units)
Figure 17. North America Drug-Coated Balloon for Coronary Artery Disease Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Drug-Coated Balloon for Coronary Artery Disease Sales YoY (2017-2028) & (Units)
Figure 19. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Sales YoY (2017-2028) & (Units)
Figure 21. Asia-Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales YoY (2017-2028) & (Units)
Figure 23. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Sales YoY (2017-2028) & (Units)
Figure 25. Middle East & Africa Drug-Coated Balloon for Coronary Artery Disease Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Drug-Coated Balloon for Coronary Artery Disease Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Drug-Coated Balloon for Coronary Artery Disease in the World: Market Share by Drug-Coated Balloon for Coronary Artery Disease Revenue in 2021
Figure 28. Global Drug-Coated Balloon for Coronary Artery Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2017-2028)
Figure 30. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2017-2028)
Figure 31. Global Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2017-2028)
Figure 32. Global Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2017-2028)
Figure 33. North America Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2017-2028)
Figure 34. North America Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2017-2028)
Figure 35. North America Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2017-2028)
Figure 36. North America Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2017-2028)
Figure 37. North America Drug-Coated Balloon for Coronary Artery Disease Sales Share by Country (2017-2028)
Figure 38. North America Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Country (2017-2028)
Figure 39. United States Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2017-2028)
Figure 42. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2017-2028)
Figure 43. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2017-2028)
Figure 44. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2017-2028)
Figure 45. Europe Drug-Coated Balloon for Coronary Artery Disease Sales Share by Country (2017-2028)
Figure 46. Europe Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Country (2017-2028)
Figure 47. Germany Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 48. France Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Region (2017-2028)
Figure 58. China Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 61. India Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2017-2028)
Figure 68. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2017-2028)
Figure 70. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Drug-Coated Balloon for Coronary Artery Disease Sales Share by Country (2017-2028)
Figure 72. Latin America Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Country (2017-2028)
Figure 73. Mexico Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 76. Colombia Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Drug-Coated Balloon for Coronary Artery Disease Revenue Share by Country (2017-2028)
Figure 83. Turkey Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Drug-Coated Balloon for Coronary Artery Disease Revenue (2017-2028) & (US$ Million)
Figure 86. Drug-Coated Balloon for Coronary Artery Disease Value Chain
Figure 87. Drug-Coated Balloon for Coronary Artery Disease Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed